Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1991 1
1994 1
1995 1
2001 1
2003 1
2011 1
2013 2
2014 1
2015 2
2016 1
2017 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Uterine leiomyosarcoma: a review article.
Gockley AA, Rauh-Hain JA, del Carmen MG. Gockley AA, et al. Int J Gynecol Cancer. 2014 Nov;24(9):1538-42. doi: 10.1097/IGC.0000000000000290. Int J Gynecol Cancer. 2014. PMID: 25304676 Review.
Uterine leiomyosarcomas (LMSs) are rare aggressive tumors, with high recurrence rates, even when confined to the uterine corpus at the time of diagnosis. ...
Uterine leiomyosarcomas (LMSs) are rare aggressive tumors, with high recurrence rates, even when confined to the uterine co
Heterologous and rare homologous sarcomas of the uterine corpus: a clinicopathologic review.
Fadare O. Fadare O. Adv Anat Pathol. 2011 Jan;18(1):60-74. doi: 10.1097/PAP.0b013e3182026be7. Adv Anat Pathol. 2011. PMID: 21169739 Review.
Pure sarcomas of the uterine corpus are uncommon, constituting less than 3% of all malignancies at this site, and most of them are leiomyosarcomas and endometrial stromal sarcomas. ...In this article, the clinicopathologic attributes of all earlier reported sarcomas …
Pure sarcomas of the uterine corpus are uncommon, constituting less than 3% of all malignancies at this site, and most of them …
Gynecological sarcomas.
DiSaia PJ, Pecorelli S. DiSaia PJ, et al. Semin Surg Oncol. 1994 Sep-Oct;10(5):369-73. doi: 10.1002/ssu.2980100510. Semin Surg Oncol. 1994. PMID: 7997731 Review.
Sarcomas of the uterus, ovary and lower genital tract are fortunately rare, since the prognosis is quite often poor. The most frequent are sarcomas of the uterine corpus, and these account for only 4% of all uterine tumors. ...
Sarcomas of the uterus, ovary and lower genital tract are fortunately rare, since the prognosis is quite often poor. The most frequen …
Malignant tumors of the uterine corpus: molecular background of their origin.
Brany D, Dvorska D, Nachajova M, Slavik P, Burjanivova T. Brany D, et al. Tumour Biol. 2015 Sep;36(9):6615-21. doi: 10.1007/s13277-015-3824-1. Epub 2015 Aug 26. Tumour Biol. 2015. PMID: 26307392 Review.
Tumors of the uterine corpus can be divided into two main groups: endometrial tumors and mesenchymal tumors. ...This view includes a different expression pattern of genes, usually aberrant in cases of uterine cancer that can arise due to epigenetic modificati …
Tumors of the uterine corpus can be divided into two main groups: endometrial tumors and mesenchymal tumors. ...This view incl …
Recent Developments in Surgical Pathology of the Uterine Corpus.
Hanley KZ, Birdsong GG, Mosunjac MB. Hanley KZ, et al. Arch Pathol Lab Med. 2017 Apr;141(4):528-541. doi: 10.5858/arpa.2016-0284-SA. Epub 2017 Feb 28. Arch Pathol Lab Med. 2017. PMID: 28353387 Free article. Review.
There have been several updates recently on the classification of uterine tumors. Endometrial carcinomas have traditionally been divided into 2 types, but some are difficult to classify and do not fit readily into either of the currently recognized categories. ...The new d …
There have been several updates recently on the classification of uterine tumors. Endometrial carcinomas have traditionally been divi …
Major clinical research advances in gynecologic cancer in 2014.
Suh DH, Lee KH, Kim K, Kang S, Kim JW. Suh DH, et al. J Gynecol Oncol. 2015 Apr;26(2):156-67. doi: 10.3802/jgo.2015.26.2.156. J Gynecol Oncol. 2015. PMID: 25872896 Free PMC article. Review.
In 2014, 9 topics were selected as major advances in clinical research for gynecologic oncology: 2 each in cervical and corpus cancer, 4 in ovarian cancer, and 1 in breast cancer. For cervical cancer, several therapeutic agents showed viable antitumor clinical response in …
In 2014, 9 topics were selected as major advances in clinical research for gynecologic oncology: 2 each in cervical and corpus cancer …
Major clinical research advances in gynecologic cancer in 2015.
Suh DH, Kim M, Kim HJ, Lee KH, Kim JW. Suh DH, et al. J Gynecol Oncol. 2016 Nov;27(6):e53. doi: 10.3802/jgo.2016.27.e53. J Gynecol Oncol. 2016. PMID: 27775259 Free PMC article. Review.
For cervical cancer, update of human papillomavirus vaccines regarding two-dose regimen, 9-valent vaccine, and therapeutic vaccine was reviewed. For corpus cancer, the safety concern of power morcellation in presumed fibroids was explored again with regard to age and preva …
For cervical cancer, update of human papillomavirus vaccines regarding two-dose regimen, 9-valent vaccine, and therapeutic vaccine was revie …
Phase II study of niraparib in recurrent or persistent rare fraction of gynecologic malignancies with homologous recombination deficiency (JGOG2052).
Asano H, Oda K, Yoshihara K, Ito YM, Matsumura N, Shimada M, Watari H, Enomoto T. Asano H, et al. J Gynecol Oncol. 2022 Jul;33(4):e55. doi: 10.3802/jgo.2022.33.e55. Epub 2022 May 3. J Gynecol Oncol. 2022. PMID: 35557035 Free PMC article. Review.
BACKGROUND: Poly (adenosine diphosphate)-ribose polymerase (PARP) inhibitors for tumors with homologous recombination deficiency (HRD), including pathogenic mutations in BRCA1/2, have been developed. Genomic analysis revealed that about 20% of uterine leiomyosarcoma
BACKGROUND: Poly (adenosine diphosphate)-ribose polymerase (PARP) inhibitors for tumors with homologous recombination deficiency (HRD), incl …
Malignant lesions of the female genital tract and peritoneum that may be underdiagnosed.
Young RH, Clement PB. Young RH, et al. Semin Diagn Pathol. 1995 Feb;12(1):14-29. Semin Diagn Pathol. 1995. PMID: 7770671 Review.
The latter subtype has only recently been described. Endometrioid adenocarcinomas, usually of the uterine corpus, but occasionally of other sites, may have microglandular patterns that can lead to their misdiagnosis, sometimes as microglandular hyperplasia. ...Other …
The latter subtype has only recently been described. Endometrioid adenocarcinomas, usually of the uterine corpus, but occasion …
Carcinosarcoma of the corpus uteri (Malignant Mullerian Mixed Tumor): a case report in Yaounde (Cameroon).
Sando Z, Fouelifack FY, Fouogue JT, Fouedjio JH, Anoudem CE, Nangue C. Sando Z, et al. Pan Afr Med J. 2013 Dec 19;16:145. doi: 10.11604/pamj.2013.16.145.3497. eCollection 2013. Pan Afr Med J. 2013. PMID: 24876903 Free PMC article. Review.
Carcinosarcoma of the uterus is a rare tumor representing 2-4% of uterine malignancies. ...We report a first documented case of carcinosarcoma occurring in a 62 years old woman who presented with postmenopausal vaginal bleeding for one year. The preoperative biopsy …
Carcinosarcoma of the uterus is a rare tumor representing 2-4% of uterine malignancies. ...We report a first documented case o …
15 results